The following is a statement from Ted Okon, executive director of the Community Oncology Alliance, on recent CMS expansions in light of COVID-19.
The Leukemia & Lymphoma Society and its partners developed the LLS COVID-19 Patient Financial Aid Program to provide $250 for eligible blood cancer patients struggling with the economic hardship because of COVID-19.
The APLICOV clinical trial protocol for Aplidin (plitidepsin) was submitted to the Spanish Medicines and Healthcare Products Agency.
A unique subgroup of patients who have COVID-19 with low severity disease experienced digestive symptoms, most notably diarrhea, according to a study published in The American Journal of Gastroenterology.
Versiti Inc. in early April plans to collect plasma from recovered COVID-19 patients to help treat others with the virus.
Janice Cowden, a Florida resident who has metastatic breast cancer and symptoms of the novel coronavirus, has tested negative for COVID-19 after a lengthy process that involved being denied testing multiple times—despite her vulnerable status (The Cancer Letter, March 20).
This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full list of our coverage, as well as the latest meeting cancellations, is available here.
Social isolation and containment have begun to flatten the curve of COVID-19 cases in Italy, Giuseppe Curigliano said to The Cancer Letter.
This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full list of our coverage, as well as the latest meeting cancellations, is available here.
